“To Determine the Frequency of Biochemical Adverse Effects in Patients on Meglumine Antimoniate Treatment for Cutaneous Leishmaniasis”. Medical Forum Monthly 30, no. 9 (May 2, 2024). Accessed December 26, 2025. https://medicalforummonthly.com/index.php/mfm/article/view/3872.